Rabies is a major neglected zoonotic disease and causes a substantial burden in the Asian region. Currently, Pacific Oceania is free of rabies but enzootic areas throughout southeast Asia represent a major risk of disease introduction to this region. On September 25–26, 2019, researchers, government officials and related stakeholders met at an IABS conference in Bangkok, Thailand to engage on the topic of human rabies mediated by dogs. The objective of the meeting was focused upon snowballing efforts towards achieving substantial progress in rabies prevention, control and elimination within Asia by 2030, and thereby to safeguard the Pacific region. Individual sessions focused upon domestic animal, wildlife and human vaccination; the production and evaluation of quality, safety and efficacy of existing rabies biologics; and the future development of new products. Participants reviewed the progress to date in eliminating canine rabies by mass vaccination, described supportive methods to parenteral administration by oral vaccine application, considered updated global and local approaches at human prophylaxis and discussed the considerable challenges ahead. Such opportunities provide continuous engagement on disease management among professionals at a trans-disciplinary level and promote new applied research collaborations in a modern One Health context.

狂犬病是一种被忽视的主要人畜共患病，在亚洲地区造成了沉重负担。目前，太平洋大洋洲没有狂犬病，但整个东南亚的动物共生地区是该地区传染病的主要风险。2019年9月25日至26日，研究人员，政府官员和相关利益相关者在泰国曼谷举行的IABS会议上开会，讨论了狗介导的人类狂犬病这一主题。这次会议的目标是集中力量，在2030年前在亚洲范围内实现狂犬病的预防，控制和消除方面取得实质性进展，从而保护太平洋地区。个别会议的重点是家畜，野生动植物和人类疫苗接种；现有狂犬病生物制剂的质量，安全性和功效的生产和评估；以及新产品的未来发展。与会者回顾了迄今为止通过大规模疫苗接种消除犬狂犬病的进展，描述了通过口服疫苗进行肠胃外给药的支持方法，考虑了预防人类疾病的全球和局部最新方法，并讨论了未来的巨大挑战。这样的机会使跨学科的专业人士不断参与疾病管理，并在现代的“一个健康”环境中促进新的应用研究合作。